v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (3,642) $ (19,835)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 134 131
Accretion and amortization on investments, net (1,069) (2,210)
Amortization of debt issuance costs/debt discounts 286 253
Non-cash interest expense on liabilities for sales of future royalties 3,912 4,801
Stock-based compensation expense 4,913 7,423
Amortization of right-of-use assets 192 177
Increase in allowance for doubtful accounts 0 131
Changes in assets and liabilities:    
Inventory (16,651) (17,508)
Accounts receivable, net (4,894) 4,649
Prepaid expenses and other assets (2,234) (1,688)
Accounts payable 1,463 (563)
Accrued compensation and benefits (21,009) (13,204)
Accrued liabilities (20,374) (6,663)
Payments on royalty agreement (3,721) (3,682)
Operating lease liabilities (212) (191)
Net cash used in operating activities (62,906) (47,979)
Cash flows from investing activities:    
Purchases of property and equipment (252) 32
Purchases of marketable securities (34,525) (46,477)
Proceeds from maturities and sales of marketable securities 86,633 98,884
Net cash provided by investing activities 51,856 52,439
Cash flows from financing activities:    
Proceeds from issuances of common stock from equity plans 914 256
Proceeds from the exercise of warrants 1,511 0
Net cash provided by financing activities 2,425 256
Net effect of exchange rates on cash, cash equivalents and restricted cash (36) 18
Net increase (decrease) in cash, cash equivalents and restricted cash (8,661) 4,734
Cash, cash equivalents and restricted cash at the beginning of the period 79,440 80,876
Cash, cash equivalents and restricted cash at the end of the period $ 70,779 $ 85,610